LJMU/TRIBE Open Lab: Accelerating R&D in Drug Delivery and Peptide Technologies

This session introduces advanced bioscience capabilities that can support organisations working in drug development, diagnostics and innovation-led R&D.

Capabilities include:

• Lipid nanoparticle (LNP) technologies
  Supporting advanced drug delivery, RNA therapeutics, and emerging modalities
• Custom peptide synthesis
  Supporting research, diagnostics, and early-stage product development

Who should attend:

• Biotech and pharmaceutical companies
• Diagnostics and medtech innovators
• Research-active academics and technical staff
• Innovation-led SMEs exploring new R&D approaches

Why attend:

• Explore how these technologies could support your current or future projects
• Understand how to access specialist facilities and expertise at LJMU
• Identify opportunities for collaboration or funded research
• Connect with researchers and industry professionals in a focused setting

Session format:

• Small, discussion-led session (maximum 8 attendees)
• Designed to introduce capability and explore practical applications
• Opportunity to discuss next steps and collaboration